Kieler M - Search Results

1

Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior.

Bianconi D, Fabian E, Herac M, Kieler M, Thaler J, Prager G, Unseld M. Bianconi D, et al. Among authors: kieler m. J Cancer. 2022 Apr 18;13(7):2271-2280. doi: 10.7150/jca.70500. eCollection 2022. J Cancer. 2022. PMID: 35517419 Free PMC article.

2

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease.

Kieler M, Scheithauer W, Zielinski CC, Chott A, Al-Mukhtar A, Prager G. Kieler M, et al. ESMO Open. 2016 Dec 15;1(6):e000084. doi: 10.1136/esmoopen-2016-000084. eCollection 2016. ESMO Open. 2016. PMID: 28255450 Free PMC article.

3

Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel.

Bianconi D, Heller G, Spies D, Herac M, Gleiss A, Liebmann-Reindl S, Unseld M, Kieler M, Scheithauer W, Streubel B, Zielinski CC, Prager GW. Bianconi D, et al. Among authors: kieler m. Sci Rep. 2017 Jul 7;7(1):4851. doi: 10.1038/s41598-017-04743-0. Sci Rep. 2017. PMID: 28687745 Free PMC article.

4

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer.

Kieler M, Unseld M, Bianconi D, Prager GW. Kieler M, et al. Memo. 2017;10(3):136-140. doi: 10.1007/s12254-017-0352-2. Epub 2017 Sep 7. Memo. 2017. PMID: 28989542 Free PMC article. Review.

5

Challenges and Perspectives for Immunotherapy in Adenocarcinoma of the Pancreas: The Cancer Immunity Cycle.

Kieler M, Unseld M, Bianconi D, Prager G. Kieler M, et al. Pancreas. 2018 Feb;47(2):142-157. doi: 10.1097/MPA.0000000000000970. Pancreas. 2018. PMID: 29346215 Review.

6

Analysis of 10 Adrenocortical Carcinoma Patients in the Cohort of the Precision Medicine Platform MONDTI.

Kieler M, Müllauer L, Koperek O, Bianconi D, Unseld M, Raderer M, Prager GW. Kieler M, et al. Oncology. 2018;94(5):306-310. doi: 10.1159/000486678. Epub 2018 Feb 14. Oncology. 2018. PMID: 29444511

7

Regorafenib therapy in metastatic colorectal cancer patients: markers and outcome in an actual clinical setting.

Unseld M, Filip M, Seirl S, Gleiss A, Bianconi D, Kieler M, Demyanets S, Scheithauer W, Zielinski C, Prager G. Unseld M, et al. Among authors: kieler m. Neoplasma. 2018;65(4):599-603. doi: 10.4149/neo_2018_170727N506. Neoplasma. 2018. PMID: 29940763

8

Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib.

Unseld M, Drimmel M, Siebenhüner A, Gleiss A, Bianconi D, Kieler M, Scheithauer W, Winder T, Prager GW. Unseld M, et al. Among authors: kieler m. Clin Colorectal Cancer. 2018 Dec;17(4):274-279. doi: 10.1016/j.clcc.2018.05.012. Epub 2018 Jun 8. Clin Colorectal Cancer. 2018. PMID: 30042010

9

SERPINB7 Expression Predicts Poor Pancreatic Cancer Survival Upon Gemcitabine Treatment.

Bianconi D, Herac M, Spies D, Kieler M, Brettner R, Unseld M, Fürnkranz K, Famler B, Schmeidl M, Minichsdorfer C, Zielinski C, Heller G, Prager GW. Bianconi D, et al. Among authors: kieler m. Transl Oncol. 2019 Jan;12(1):15-23. doi: 10.1016/j.tranon.2018.08.019. Epub 2018 Sep 20. Transl Oncol. 2019. PMID: 30245304 Free PMC article.

10

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy.

Kieler M, Unseld M, Wojta J, Kaider A, Bianconi D, Demyanets S, Prager GW. Kieler M, et al. Med Oncol. 2018 Nov 13;36(1):1. doi: 10.1007/s12032-018-1223-3. Med Oncol. 2018. PMID: 30426271 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page